Introduction: With the recent availability of fully covered, removable esophageal stents (CRES), endoscopic stenting has been utilized to treat refractory BES. We aimed to review the feasibility and effectiveness of CRES to treat BES at our institution. Methods: We retrospectively identified all patients with solid food dysphagia receiving CRES for the treatment of refractory BES at our institution from 2004-2008 using a combination of manufacturer's stent logs, fluoroscopy records, and our endoscopic database. Patient demographics, stricture etiology and location, stent and procedure characteristics, and clinical outcomes were obtained. Results: Twenty patients with a mean age of 69 (70% male) underwent attempted CRES placement for BES during the study period. Stricture etiologies included: anastamotic (10), radiation (5), chemotherapy (1), scleroderma (1), peptic (1), and unknown (2). Average stricture length was 4 cm. Stricture locations were: upper third (7), middle (7), and distal (6). Stent types placed included Alveolus (Charlotte, NC) in 75% of patients with 25% receiving Polyflex (Boston Scientific, Natick, MA) stents. The average initial duration of CRES placement was 76 days with a mean clinical follow-up time of 9 months. Attempted placement of 21 CRES was performed in 20 patients. Eight patients required 9 additional stents during follow-up. One failed deployment due to immediate stent migration occurred, for an overall technical success rate of 97%. No bleeding complications occurred, but 5 patients developed chest pain with 1 requiring hospitalization. A total of 26% (5/19) of subjects died prior to stent removal. Stent migration occurred in 37% (7/19) of patients. Five of these patients underwent additional therapy (repeat stent-1, repeat dilation-1, or both-3), while one patient had resolution of symptoms and one has required continued tube feeds. Of the 7 patients without stent migration, two had symptom resolution with 5 requiring continued therapy (repeat stent-2, repeat dilation-1, or both-2). Of a total of 14 patients with initial stent removal, only 21% of patients achieved symptom resolution without repeat therapy. When additional therapy during the follow-up period was included, only one additional patient achieved symptom resolution for a total success rate of 28%. Conclusions: Although placement of CRES for BES is technically feasible, it is frequently complicated by stent migration and chest pain in refractory BES. In addition, few patients achieved long-term stricture resolution after initial stenting. In this study, most patients required repeated stenting and/or dilations to maintain relief of dysphagia.